Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00307_DB00823> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00307_DB00823 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00307_DB00823 label "DDI between Bexarotene and Ethynodiol - Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of ethynodiol diacetate it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form). [drugbank_resource:DB00307_DB00823]" assertion.
- drugbank_resource:DB00307_DB00823 identifier "drugbank_resource:DB00307_DB00823" assertion.
- drugbank_resource:DB00307_DB00823 title "DDI between Bexarotene and Ethynodiol - Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of ethynodiol diacetate it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form)." assertion.